Literature DB >> 23207712

Comparison between high-resolution CT and MRI using a very short echo time in patients with cystic fibrosis with extra focus on mosaic attenuation.

Matthias Teufel1, Dominik Ketelsen, Sabrina Fleischer, Petros Martirosian, Ulrike Graebler-Mainka, Martin Stern, Claus D Claussen, Fritz Schick, Juergen F Schaefer.   

Abstract

BACKGROUND: It would be beneficial to establish pulmonary MRI as a complementary approach to CT for direct visualization of mosaic perfusion, bullae, and emphysema in patients with cystic fibrosis.
OBJECTIVES: The purpose of this study was to compare both modalities, CT and MRI, using the Helbich-Bhalla score with a special focus on reliable detection of a mosaic pattern.
METHODS: Out of 51 patients examined by MRI on a 1.5-Tesla system during a period of 2 years, 19 patients were scheduled for additional low-dose CT in a clinical context. The MRI protocol comprised a gradient echo (GRE) sequence with a very short echo time (TE = 0.8 ms) in inspiration and expiration, a 3-D GRE sequence in breath hold, and a fast spin echo sequence with respiration and ECG triggering. MDCT was carried out in inspiration and adapted to body weight using 100 or 120 kV, 30-60 mA, 1- and 3-mm slice thicknesses, as well as low and high kernels. Additionally incremental slices in 3 positions were recorded in expiration for distinct detection of air trapping. CT and MRI analyses were performed by two radiologic readers in consensus unaware of the clinical parameters. The Helbich-Bhalla score of both examinations was correlated. Mean difference and accordance were assessed in each category.
RESULTS: There was a strong correlation between CT and MRI (R = 0.87, p < 0.01). The mean Helbich-Bhalla score for CT was 12.2 (range 1-18) and for MRI it was 11.7 (range 2-19). The mean difference was 0.5 points. Besides this strong correlation for findings (bronchiectasis, mucus plugging, peribronchial thickening, and consolidation) with a prolonged T2 TE in MRI, we could also state a qualitative agreement of 95-100% in the categories with short T2 and low signal intensity in MRI as emphysema, bullae, and mosaic perfusion.
CONCLUSIONS: These results suggest that in our patient group none of the relevant findings were missed by MR imaging and reading.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23207712     DOI: 10.1159/000343085

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  7 in total

Review 1.  Pediatric Chest MRI: A Review.

Authors:  Savinay Kapur; Ashu Seith Bhalla; Manisha Jana
Journal:  Indian J Pediatr       Date:  2019-02-05       Impact factor: 1.967

2.  A semiquantitative MRI-Score can predict loss of lung function in patients with cystic fibrosis: Preliminary results.

Authors:  Juergen F Schaefer; Andreas Hector; Katharina Schmidt; Matthias Teufel; Sabrina Fleischer; Ute Graepler-Mainka; Joachim Riethmueller; Sergios Gatidis; Susanne Schaefer; Konstantin Nikolaou; Dominik Hartl; Ilias Tsiflikas
Journal:  Eur Radiol       Date:  2017-06-29       Impact factor: 5.315

Review 3.  Computed tomography dose optimisation in cystic fibrosis: A review.

Authors:  Helena Ferris; Maria Twomey; Fiachra Moloney; Siobhan B O'Neill; Kevin Murphy; Owen J O'Connor; Michael Maher
Journal:  World J Radiol       Date:  2016-04-28

4.  New severity assessment in cystic fibrosis: signal intensity and lung volume compared to LCI and FEV1: preliminary results.

Authors:  Sabrina Fleischer; Mareen Sarah Kraus; Sergios Gatidis; Winfried Baden; Andreas Hector; Dominik Hartl; Ilias Tsiflikas; Juergen Frank Schaefer
Journal:  Eur Radiol       Date:  2019-11-14       Impact factor: 5.315

5.  Free-breathing pediatric chest MRI: Performance of self-navigated golden-angle ordered conical ultrashort echo time acquisition.

Authors:  Evan J Zucker; Joseph Y Cheng; Anshul Haldipur; Michael Carl; Shreyas S Vasanawala
Journal:  J Magn Reson Imaging       Date:  2017-06-01       Impact factor: 4.813

Review 6.  Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis.

Authors:  Jürgen Schäfer; Matthias Griese; Ravishankar Chandrasekaran; Sanjay H Chotirmall; Dominik Hartl
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

7.  Correlative 3D Imaging and Microfluidic Modelling of Human Pulmonary Lymphatics using Immunohistochemistry and High-resolution μCT.

Authors:  Stephanie K Robinson; Jonathan J Ramsden; Jane Warner; Peter M Lackie; Tiina Roose
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.